CryoVault™ is a scalable, robust, completely single-use freeze and thaw platform for biopharmaceuticals.
This end-to-end solution provides the industry leading implementation of this demanding unit processing operation.
- CryoVault™ can be seamlessly scaled from process development through clinical to full scale commercial production. Consistency in freeze-thaw performance throughout the various scales of operation is a key performance attribute of the system.
- The platform is not only scalable from a freeze-thaw performance perspective, but also from an operational standpoint. CryoVault™ scales operationally with your volume requirements by providing containers that can hold up to 75 L, along with all the associated material handling infrastructure.
- CryoVault™ addresses the need to provide fluid integrity. The system uses robust rigid wall single-use assemblies to protect your product from fill to dispense. We understand the value of your critical biopharmaceuticals and this system provides the secure protection required.
- The platform is based on robust single-use assemblies and an integrated infrastructure that provides process solutions to ensure the security of your product.
- CryoVault™ embraces the operational benefits associated with single-use systems. It is cost effective, simple to operate, clean, and can even be recycled.
End-to-End Process Solution
The CryoVault™ platform provides an end-to-end process solution for your entire freeze-thaw process. The system has been proven to provide robust performance from fill to dispense, and every process step in between.
CryoVault™ has been designed as a modular system to accommodate a high degree of flexibility for different batch volumes. All system components seamlessly integrate with each other. This allows the end-user to tailor the system implementation to their specific process needs. Meissner’s applications engineering team will assist in this process.